+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Research Grant Program

National Rosacea Society

The Society awards grants of up to $25,000, or higher in special cases, for research on rosacea. Because the etiology of rosacea is unknown, high priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition. Studies may also be funded in such areas as epidemiology, predisposition, quality of life and associations with environmental and lifestyle factors. Product development studies (e.g., drug or device testing), which are more appropriately funded by commercial sources, will not be considered.

Grant Application Form

The National Rosacea Society is currently accepting proposals for research grants to be awarded in 2025. Applications should be submitted by July 1, 2025.

AI Based Application Success Predictor
1. Focus on Rosacea Disease Mechanisms

High priority is given to studies exploring pathogenesis, progression, mechanisms of action, cell biology, and genetic factors of rosacea

Secondary areas include epidemiology, predisposition, quality of life, and the roles of environmental or lifestyle factors

Product development (drug/device testing) is excluded, as commercial avenues cover this domain researchfunding.duke.edu+4webmail.rosacea.org+4hmpgloballearningnetwork.com+4.

💰 2. Ideal Budget and Scope

Typical grants offer up to $25,000, with occasional higher awards available rosacea.org+9webmail.rosacea.org+9webmail.rosacea.org+9.

Designed as pilot or seed funding to enable initial data that pave the way for larger studies en.wikipedia.org+11webmail.rosacea.org+11hmpgloballearningnetwork.com+11.

👥 3. Peer Review by Experts

The NRS Medical Advisory Board—comprised of dermatology leaders from top institutions—make award decisions healio.com+12webmail.rosacea.org+12hmpgloballearningnetwork.com+12.

Studies range from cell biology to microbiome and neurovascular interactions rosacea.org+15rosacea.org+15rosacea.org+15.

🎓 4. Investigator & Institutional Alignment

Grant recipients include researchers across career stages—from junior investigators to established labs researchfunding.duke.edu+4medestheticsmag.com+4arxiv.org+4.

Demonstrated institutional support and alignment with rosacea research increases viability.

🧪 5. Demonstrated Impact & Prior Breakthroughs

Past grants have led to major findings, such as the role of cathelicidins, mast cells, Demodex mites, genetics, and neurovascular peptides hmpgloballearningnetwork.com+7webmail.rosacea.org+7healio.com+7.

Preferred proposals show clear potential to advance understanding or lead new therapeutic strategies.

🕒 6. Competitive and Well-Defined Timeline

Deadlines are typically July 1 each year, with about 78 grants totaling ~$1.7 M awarded since 2000 rosacea.orgresearchfunding.duke.edu+5webmail.rosacea.org+5thedermdigest.com+5.

Grants are sized for short–term (12–24 months) preliminary research.

🧩 Summary – What Makes a Strong NRS Application

Predictor	Explanation
Scientific fit	Crisp focus on rosacea mechanisms or epidemiologic or QoL studies
Budget-appropriate pilot scope	Clear pilot plan justified within ~$25K
Expert relevance	Aligns with Medical Advisory Board’s research priorities
Institutional readiness	Appropriate team, environment, and career stage
Potential to advance field	Builds toward new insights or follow-up funding
Timely submission	Meets July 1 deadline for small, fast studies

✅ Tips for a Competitive Submission

Target mechanisms of rosacea—immune, vascular, neural, microbial, genetic.

Craft a focused pilot study with clear aims, timeline, and $25K‑budgeted costs.

Show institutional support, even if internal, and your ability to deliver data.

Highlight how your findings will open new research directions or inform treatment.

Consult the Medical Advisory Board’s interests—cell/molecular insights are well-received.

Stick to deadline and funding limits—application window and scope are strict.

Specialties

Cell Biology

Others

Genetics & Genomics

Eligibility Requirements

Priority is given to research in such areas as the pathogenesis, progression, mechanism of action, cell biology and potential genetic factors of this conspicuous and often life-disruptive condition.

Sponsor Details

Sponsor Institute/Organizations: National Rosacea Society

Sponsor Type: Corporate/Non-Profit

Address: 4619 N. Ravenswood Ave., Ste. 103 Chicago, IL 60640

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity